Ryan Preblick
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ryan Preblick
Ryan Preblick is recorded as CFO at Indivior Pharmaceuticals, Inc. (INDV). The proxy statement of Indivior Pharmaceuticals, Inc. reports total compensation of $3,592,393 for Ryan Preblick in fiscal 2025, including a base salary of $558,820. Disclosed compensation is on record for 3 fiscal years. Ryan Preblick has spoken on 4 earnings calls and 1 other investor event across 1 company, most recently for Indivior Pharmaceuticals, Inc. on June 3, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Indivior Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Joe Ciaffoni CEO, Board Member
- Mark Crossley CEO
- Barbara Ryan Board Member
- Daniel Ninivaggi Board Member
- Dr. David Wheadon Board Member
- Dr. Keith Humphreys Board Member
- Joseph Ciaffoni Board Member
- Juliet Thompson Board Member
- Mark Stejbach Board Member
- Stuart A. (Tony) Kingsley Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Indivior Pharmaceuticals, Inc. (INDV) | Chief Financial Officer | $558,820 | $3,592,393 |
| 2024 | Indivior Pharmaceuticals, Inc. (INDV) | Chief Financial Officer | $539,922 | $2,281,564 |
| 2023 | Indivior Pharmaceuticals, Inc. (INDV) | Chief Financial Officer | $516,672 | $2,397,132 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.